Dai Tianhong, Pikkula Brian M, Tunnell James W, Chang David W, Anvari Bahman
Department of Bioengineering, Rice University, Houston, Texas 77251, USA.
Lasers Surg Med. 2003;33(1):16-24. doi: 10.1002/lsm.10183.
Improved laser treatment of cutaneous hypervascular lesions is expected by utilizing higher incident dosages, longer pulse durations and longer wavelengths than those currently used in clinical settings. However, simply increasing the incident dosage will also increase the risk of nonspecific thermal injury to the epidermis due to light absorption by melanin. In this study, we investigated the thermal response of human skin epidermis to 595-nm wavelength laser irradiation at high incident dosages (up to 20 J/cm(2)) and long pulse durations (up to 40 milliseconds) in conjunction with cryogen spray cooling (CSC) using ex-vivo human skin samples.
STUDY DESIGN/MATERIALS AND METHODS: The Candela V-beam trade mark laser (595-nm wavelength) was used in the experiments. Ex-vivo human skin samples (Fitzpatrick types I-VI) were irradiated at the incident dosages D(0) = 4, 6, 10, 15, and 20 J/cm(2), laser pulse durations tau(laser) = 1.5, 10, and 40 milliseconds, without and with CSC (refrigerant-134A, spurt duration tau(CSC) = 100 milliseconds). Thermal injury to the epidermis was evaluated by histological observations.
Under the same incident dosage, longer pulse durations led to reduced thermal injury to the epidermis. Without CSC, no demonstrable thermal injury to the epidermis was observed in skin types I-II irradiated at the incident dosage as high as 15 J/cm(2), and in skin types III-IV at 10 J/cm(2). When CSC was applied, no evidence of thermal injury to the epidermis was present in skin types I-II even when irradiated at the maximum available incident dosage of the laser system (20 J/cm(2)). In skin types III-IV, no demonstrable thermal injury to the epidermis was observed when using incident dosage as high as 15 J/cm(2) in conjunction with CSC. In skin type VI, thermal injury to the epidermis could not be avoided even at the setting D(0) = 4 J/cm(2), tau(laser) = 40 milliseconds in conjunction with CSC.
For a given incident dosage, longer pulse durations help reduce thermal injury to the epidermis. When a 100-millisecond cryogen spurt is applied, thermal injury to the epidermis can be prevented in ex-vivo skin types I-IV when irradiated at higher incident dosages (15-20 J/cm(2)) than those currently used in clinical settings. Further studies on optimizing the CSC parameters in conjunction with the laser irradiation parameters are needed to protect skin types V-VI from thermal injury to the epidermis.
通过使用比临床环境中目前所使用的更高的入射剂量、更长的脉冲持续时间和更长的波长,有望改进对皮肤血管增生性病变的激光治疗。然而,单纯增加入射剂量也会因黑色素吸收光而增加对表皮非特异性热损伤的风险。在本研究中,我们使用离体人体皮肤样本,研究了在高入射剂量(高达20 J/cm²)和长脉冲持续时间(高达40毫秒)下,595纳米波长激光照射结合冷冻喷雾冷却(CSC)时人体皮肤表皮的热反应。
研究设计/材料与方法:实验中使用了科医人V型光束商标激光(595纳米波长)。对离体人体皮肤样本(Fitzpatrick I - VI型)在入射剂量D(0)=4、6、10、15和20 J/cm²、激光脉冲持续时间tau(laser)=1.5、10和40毫秒的条件下进行照射,分别在不使用和使用CSC(制冷剂 - 134A,喷射持续时间tau(CSC)=100毫秒)的情况下。通过组织学观察评估表皮的热损伤情况。
在相同入射剂量下,较长的脉冲持续时间可减少对表皮的热损伤。在不使用CSC时,对于I - II型皮肤,在入射剂量高达15 J/cm²时未观察到对表皮有明显的热损伤;对于III - IV型皮肤,在入射剂量为10 J/cm²时未观察到明显热损伤。当应用CSC时,对于I - II型皮肤,即使在激光系统的最大可用入射剂量(20 J/cm²)下照射,也未发现表皮有热损伤的迹象。对于III - IV型皮肤,在使用高达15 J/cm²的入射剂量并结合CSC时,未观察到对表皮有明显的热损伤。对于VI型皮肤,即使在D(0)=4 J/cm²、tau(laser)=40毫秒并结合CSC的设置下,也无法避免对表皮的热损伤。
对于给定的入射剂量,较长的脉冲持续时间有助于减少对表皮的热损伤。当应用100毫秒的冷冻剂喷射时,对于I - IV型离体皮肤,在高于临床环境中目前所使用的入射剂量(15 - 20 J/cm²)下照射时,可防止对表皮的热损伤。需要进一步研究优化CSC参数与激光照射参数的结合,以保护V - VI型皮肤免受表皮热损伤。